NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

Phase II Study of 177Lu-DOTATATE Radionuclide in Adults With Progressive or High-risk Meningioma

Phase 2

Active, not recruiting

Conditions: Meningioma

Interventions: Drug: Lutathera

First Posted Date: 2019-06-03

Last Posted Date: 2024-06-24

Lead Sponsor: NYU Langone Health

Target Recruit Count: 32

Registration Number: NCT03971461

Locations: 🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States
🇺🇸
NYU Langone Health, New York, New York, United States

A Comparison of the Outcomes of Distal Fingertip Amputations Treated With Either Artificial (Xeroform) or Biological Dressings

Withdrawn

Conditions: Finger Injuries
Amputation, Traumatic

Interventions: Other: Skin Graft
Other: Bacitracin

First Posted Date: 2019-05-30

Last Posted Date: 2020-05-29

Lead Sponsor: NYU Langone Health

Registration Number: NCT03968835

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Effectiveness of Malaria Camps as Part of the Odisha State Malaria Elimination Drive

Not Applicable

Completed

Conditions: Malaria

Interventions: Other: Malaria Camps

First Posted Date: 2019-05-28

Last Posted Date: 2022-01-11

Lead Sponsor: NYU Langone Health

Target Recruit Count: 2463

Registration Number: NCT03963869

Locations: 🇮🇳
Community Welfare Society Hospital, Rourkela, Odisha, India

Cyberknife for Early Stage Breast Cancer

Not Applicable

Completed

Conditions: Early Stage Breast Cancer

Interventions: Radiation: Cyberknife for Early Stage Breast Cancer

First Posted Date: 2019-05-13

Last Posted Date: 2021-02-18

Lead Sponsor: NYU Langone Health

Target Recruit Count: 26

Registration Number: NCT03946683

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Nebulized Furosemide in Premature Infants With Bronchopulmonary Dysplasia - A Cross Over Pilot Study of Its Efficacy and Safety

Early Phase 1

Withdrawn

Conditions: Premature Infant
Premature Birth

Interventions: Drug: Inhaled Furosemide
Drug: Intravenous Furosemide

First Posted Date: 2019-05-13

Last Posted Date: 2022-02-25

Lead Sponsor: NYU Langone Health

Registration Number: NCT03946891

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Study of the Duration and Efficacy of MYDAYIS on Adult ADHD Symptoms and Executive Function Throughout the Day Into the Early Evening

Phase 3

Completed

Conditions: Attention Deficit-Hyperactivity

Interventions: Drug: MYDAYIS
Drug: Placebo

First Posted Date: 2019-05-10

Last Posted Date: 2024-03-08

Lead Sponsor: NYU Langone Health

Target Recruit Count: 52

Registration Number: NCT03945175

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

High-Dose Post-Transplant Cyclophosphamide and Bortezomib (CyBor) for the Prevention of Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Phase 2

Completed

Conditions: GVHD

Interventions: Drug: Bortezomib
Drug: Cyclophosphamide

First Posted Date: 2019-05-10

Last Posted Date: 2024-03-07

Lead Sponsor: NYU Langone Health

Target Recruit Count: 23

Registration Number: NCT03945591

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Pediatric Parenting Support in Flint

Not Applicable

Active, not recruiting

Conditions: Healthy
Family Research

Interventions: Behavioral: Video Interaction Project

First Posted Date: 2019-05-10

Last Posted Date: 2024-02-22

Lead Sponsor: NYU Langone Health

Target Recruit Count: 486

Registration Number: NCT03945552

Locations: 🇺🇸
Hurley Children's Hospital, Flint, Michigan, United States
🇺🇸
New York University School of Medicine, New York, New York, United States

Trial of a Distal Targeting System for Cephalomedullary Nails as Part of Surgical Repair of Hip and Femoral Shaft Fractures

Not Applicable

Completed

Conditions: Hip Fractures
Femoral Shaft Fractures

Interventions: Procedure: Distal targeting device technique of distal screw placement
Procedure: Standard of Care

First Posted Date: 2019-05-09

Last Posted Date: 2022-02-14

Lead Sponsor: NYU Langone Health

Target Recruit Count: 60

Registration Number: NCT03943329

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Abbreviated Breast MRI (AB-MRI) With Golden-angle Radial Compressed-sensing and Parallel Imaging (GRASP)

Active, not recruiting

Conditions: Breast Cancer

Interventions: Diagnostic Test: Predictive Model
Diagnostic Test: Breast Imagers

First Posted Date: 2019-04-25

Last Posted Date: 2024-12-17

Lead Sponsor: NYU Langone Health

Target Recruit Count: 264

Registration Number: NCT03927768

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy